Ancestry is an essential covariate in clinical genomics research. When genetic data are 13 available, dimensionality reduction techniques, such as principal components analysis, are 14 used to determine ancestry in complex populations. Unfortunately, these data are not always 15 available in the clinical and research settings. For example, electronic health records (EHRs), 16 which are a rich source of temporal human disease data that could be used to enhance 17 genetic studies, do not directly capture ancestry. Here, we present a novel algorithm for 18 predicting genetic ancestry using only variables that are routinely captured in EHRs, such as 19 self-reported race and ethnicity, and condition billing codes. Using patients that have both 20 genetic and clinical information at Columbia University/ New York-Presbyterian Irving Medical 21 Center, we developed a pipeline that uses only clinical data to predict the genetic ancestry 22 of all patients of which more than 80% identify as other or unknown. Our ancestry estimates 23 can be used in observational studies of disease inheritance, to guide genetic cohort studies, 24 or to explore health disparities in clinical care and outcomes. 25 
Introduction
Genetic ancestry is a significant factor in disease pathogenecity and a key pillar in pre-27 cision medicine 1 . Individuals have genomic variants unique to themselves, their close rela-28 1 tives, and their ancestral populations. Measuring and characterizing the relationship between 29 these variants and clinical factors is now routine when genetic data are available. With ex- 30 isting genetic data, ancestry is estimated using principal components analysis (PCA). PCA 31 reduces dimensionality while maintaining variability, making shared ancestry in complex pop-32 ulations identifiable 2 . Despite the rapid decline in genotyping/sequencing costs 3 , genetic 33 data are not available for the majority of patients in databases of clinical records. This issue 34 is compounded by the time-consuming nature of genotyping/sequencing patients en masse 35 and complicated by issues of consent for re-use. The lack of ancestry data can adversely 36 affect analyses of clinical records. Many diseases and clinical outcomes have unidentified 37 subgroups and variants unique to these populations that can go undiscovered if not properly 38 stratified by ancestry 4 . 39 An interim goal is to use data that is routinely collected by hospitals to systematically 40 predict the genetic ancestry of patients across an electronic health record (EHR), which 41 routinely collect conditions and drug exposures variables. At Columbia University/ New 42 York-Presbyterian Hospital Irving Medical Center (CU/NYPIMC) we have access to medical 43 records from more than six million patients in a clinical data warehouse (CDW). The diversity 44 present in our CDW, in terms of race, ethnicity, and socioeconomic status, as well as the 45 depth of clinical data collected (over 20 years), makes it an ideal resource for phenotype se-46 lection and subgroup identification 5 (Table 1) . We hypothesized that these clinical data could 47 also be used to accurately predict genetic ancestry. Essentially, if two clinical concepts are 48 correlated in the EHR and one is known to have a genetic association, then those genetics 49 may also apply to the second concept 6 . Some variables collected in the EHR have clear 50 relationships to genetics, such as self-reported ethnicity and familial relationships 7 , while 51 others are more obscure, such as hypersensitivity due to exposure to the preventative HIV 52 drug abacavir is associated to the genetic variant HLA-B*5701, which is in turn associated 53 with ancestry 8, 9 . To evaluate this, we collected whole exome sequencing (WES) data from 54 the Institute for Genomic Medicine (IGM) at CU/NYPIMC for patients that also had clinical 55 data available. We used data from these patients to determine how clinical data can predict 56 ancestry and to evaluate that relationship. 57 While surname and physical address have been previously used to estimate race and 58 ethnicity 10 , the use of clinical variables as genetic surrogates of ancestry is a new approach 59 that has not yet been systematically explored. Broad phenotypes are known to have many 60 2 specific subgroups 11,12 , yet phenotypes mined from clinical data are often described as a 61 single diagnosis or trait. Clinical resources, such as EHRs, collect detailed descriptions of 62 a patient's state far beyond a given diagnosis code. Further, these records are connected 63 longitudinally, producing a rich time-line of clinical events for every patient. There is an 64 opportunity to leverage these data to identify patient subgroups. 65 For this study, we used data from the 1000 Genomes Project (1KGP) to derive a principle 66 component (PC) analysis (PCA) model and then we used this model to project the IGM data 67 into PC space. We then trained a random forest regression (RFR) algorithm to predict the 68 PC values from commonly collected clinical data and demographic data for these patients 69 and evaluated this algorithm on an independent test set of IGM patients. We found that we 70 can significantly predict the first four principal components. We then applied this algorithm to 71 all individuals with sufficient data in the EHR (4.4 million patients). We used these predicted 72 PCs to assign ancestry labels for patients and were able to predict ancestry even when 73 patients did not provide any race or ethnicity information. Our population predictions reflect 74 the census data for New York City. These clinically derived ancestry estimates can be used 75 as genetic proxies in modeling for clinical data analysis or to inform genetic studies. 76 2 Results 77 2.1 Acquiring genetic data and matching to clinical population and defining 78 a PCA model 79 We obtained 2,504 samples from 1KGP containing 5,685,915 variants and 650 samples 80 from HapMap, which were not already present in 1KGP, with 1,014,313 variants after con-81 version to the GRCh37/hg19 reference genome build. We obtained 4,132 samples from IGM 82 with 2,293,955 variants. After filtering for a minor allele frequency of at least 10% and a 83 genotyping rate of at least 90%, we identified 5,758 single nucleotide variants (SNV) match-84 ing chromosome, position, reference allele, alternate allele in common between the three 85 datasets. 86 Of the 4,132 sequenced samples available at IGM, 726 patients had structured diagnosis 87 data in the CDW at CU/NYPIMC (a total of 12 self-reported race/ ethnicity codes and 3,437 88 diagnosis codes after mapping to ICD-10). Samples that were available prior to May 2017 89 served as the training set for the RFR algorithm (N=350), and the remainder served as the 90 3 validation set (N=376). 91 We used the 5,758 common SNVs to train a PCA model on the 1KGP sample and then 92 used the model to project the IGM training set data into PC space ( Figure 1 ). The distribution 93 of the first four PCs of the HapMap and IGM patients in the training set correlated with their 94 reported race ( Figure S1 ). 95 2.2 Random forest regression algorithm accurately predicts principal com-96 ponents 97 We used diagnoses and demographic information to predict the genetic principal compo-98 nents. The diagnoses were coded in ICD10 and structured into a hierarchy with four levels 99 (Chapter, Block, Header, Terminal) . We trained RFR algorithms on features from each of the 100 four levels of ICD10 hierarchy and found that the first four PCs were predicted from the clini-101 cal data regardless of which level's features were used ( Figure 3 ). The GM model correctly 116 assigned more than 99% of 1KGP and HapMap data to their super population, each of these 117 regional groups is annotated by their cluster percentage (Table 4 ). 118 4 2.4 Ancestry prediction assign labels to ambiguous patient populations 119 Ancestry information incomplete in the EHR, more than 75% of the patients in the CU/NYIMC 120 EHR have unknown race and more than 85% have unknown ethnicity (Table 1 ). Using our 121 pipeline (the RFR algorithm and the GM model), we are able to assign an ancestry label to 122 all New York City patients (N=2,673,627) ( Table 5 ). New York City patients that reported un-123 known or other are overwhelmingly classified as Ad Mixed American based on this pipeline. 135 To further analyze the power of our pipeline, we compared the incidence rate of differ-136 ent diseases by predicted super population (Table 6, The advances in genetics, both in research and the clinic, are significant and continu-147 ously expanding. Newly available clinical data present an equally transformative opportunity. 148 These data however, are limited by issues of missingness and inaccuracy 14 . If properly ad-149 dressed, the EHR could be used as a resource to identify disease and treatment subgroups 150 that inform recruitment criteria for genetic studies and to support genetic research 15 . Cur-151 rently, these data are not being used to their full capacity, mainly due to the scarcity of linked 152 genetic data. Here, we analyzed data from the EHR in conjunction with existing genetic data 153 at CU/NYPIMC that are available for a small subset of our patients. We then utilized common 154 data elements captured by the EHR to predict patient ancestry for over 2.6 million patients, 155 who reside in New York City. 156 In this study, we collected anonymized genetic data from individuals that consented to 157 have their results used for research and merged these datasets, using 5,758 common vari-158 ants from the 1KGP populations 16 as a reference. We derived a PCA model based on data. While this model generally yielded accurate predictions, we found that the model had 169 more difficulty correctly predicting the extremes of the PC space (e.g. patients that reported 170 Asian ancestry). Accuracy of predictions are also affected by demographic differences of 171 patients used for training the machine learning algorithm versus the population of the EHR. 172 In the future, we will attempt to address these limitations by expanding the population of 173 patients with linked genetic data and by using more adaptable models 18 . 174 We used a GM Model to assign ancestry labels to the predicted PC values for the EHR 175 population. These ancestry labels are especially informative for patients for whom rave and 176 6 ethnicity data is not available or collected. Furthermore, the options that are available for 177 self-reporting are often insufficient. This is also important for researchers using the EHR for 178 data mining of populations believed to share genetic factors responsible for a disease or drug 179 response phenotype. We were able to assign ancestry information to 1,869,110 New York 180 City patients with unknown self reported race or that report other. In addition to ancestry 181 population classification, each of the 2.6 million patients also have PC values for PCs 1-4 182 predicted and available for further interpretation. While the labels are important for validation 183 and visualization, but the PC values will be more useful than categories. Proximity in PC 184 space may cross ancestry labels, but still indicative of genetic similarity relevant for disease 185 susceptibility and drug sensitivity. 186 We used the assigned ancestry to analyze the demographics of New York City by zip 187 code. The population distribution using the predicted ancestry from our pipeline by zip code 188 highly correlated with the ancestry distribution from the US Census Estimates 13 . We further 189 identified disease incidence rates between the predicted ancestry groups. The incidence 190 rate in the patients at CU/NYPIMC by ancestry group recapitulates the observed prevalence 191 between ancestry subgroups for Celiac disease 19 , cystic fibrosis 20 , Huntington's disease 21 , 192 obesity 22 , polydactyly 23 , sickle cell trait 24 , and type 2 diabetes 25 . The observed incidence 193 rate in the New York City patients for attention deficit and hyperactivity disorder does not 194 agree with the past observations 26 , which documented a lower prevalence in African can and Hispanic children compared to white children. 196 The incidence rates of trisomy 13 and 18 in the patients at CU/NYPIMC is not significantly 197 different between AFR, EAS, and EUR ancestry groups agreeing with previous analysis 27,28 , 198 which adds power to the applicability of this pipeline. The incidence rates of trisomy 21 in the 199 patients at CU/NYPIMC is not significantly different between AFR, EAS, and EUR ancestry 200 groups, which contrasts with previous observations identifying a higher prevalence in African 201 Americans compared to Asian and white populations 28 . 202 4 Conclusion 203 We have developed a new pipeline of two machine learning algorithms to predict genetic 204 ancestry using only clinical data. These predictions can be used to assign ancestry labels 205 to patients in the electronic health record for whom genetic data was previously unavailable. 206 7 This information is helpful for identifying subgroups that are likely to be ancestry specific. All datasets were processed using PLINK 29 and custom Python scripts. All SNPs were 212 filtered to exclude indels and be observed at a minor allele frequency of at least 10% and a 213 genotyping rate of at least 90%, and were normalized to a set of shared variants. 233 We trained a random forest regression model to predict PC values from clinical data us-234 ing the IGM training set. We extracted diagnosis billing codes for each patient to use as 235 features for machine learning. These codes represent what the patient was billed for for their 236 visit to the hospital and provides a general overview of their state. These data are coded 237 in either the ICD-9 (before November 2015) or ICD-10 vocabularies (after November 2015). 238 We mapped ICD-9 codes in the EHR to ICD-10 using the General Equivalence Mappings. 239 We used the heirarchical structure of the ICD-10 codes to reduce the number of features 240 that the model was trained on. We defined features at four levels of the ICD-10 hierarchy 241 (Terminal, Header, Block, Chapter). These levels are in order of decreasing specificity; for 249 We evaluated the random forest regression model performance using out-of-bag (OOB) 250 predictions. OOB produces robust estimates of performance on par to cross validation 32 . 251 For each principal component, we calculated the Pearson correlation and RMSE between 252 the actual and predicted PCs. 253 5.6 Predicting population labels 254 We used a GM model to predict ancestry labels for each individual in the EHR using the 255 first four PC values. We evaluated the predicted labels using the known labels for the indi- p-value is calculated using two-tailed two proportion Z-test between compared populations. 269 Figure 1: PC 1 vs. PC 2 1KGP, HapMap, and 
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